Bruno Falissard
AuthID: R-00J-2T5
1
TÃTULO: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) Full Text
AUTORES: Veronique Crutel; Estelle Lambert; Pierre Francois Penelaud; Cristina Albarran Severo; Joaquin Fuentes; Antoine Rosier; Amaia Hervas; Stephane Marret; Guiomar Oliveira; Mara Parellada; Simon Kyaga; Sylvie Gouttefangeas; Marianne Bertrand; Denis Ravel; Bruno Falissard;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
AUTORES: Veronique Crutel; Estelle Lambert; Pierre Francois Penelaud; Cristina Albarran Severo; Joaquin Fuentes; Antoine Rosier; Amaia Hervas; Stephane Marret; Guiomar Oliveira; Mara Parellada; Simon Kyaga; Sylvie Gouttefangeas; Marianne Bertrand; Denis Ravel; Bruno Falissard;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
AUTORES: Dominique P Germain; Perry M Elliott; Bruno Falissard; Victor V Fomin; Max J Hilz; Ana Jovanovic; Ilkka Kantola; Ales Linhart; Renzo Mignani; Mehdi Namdar; Albina Nowak; Oliveira, JP ; Maurizio Pieroni; Miguel Viana Baptista; Christoph Wanner; Marco Spada;
PUBLICAÇÃO: 2019, FONTE: MOLECULAR GENETICS AND METABOLISM REPORTS, VOLUME: 19
AUTORES: Dominique P Germain; Perry M Elliott; Bruno Falissard; Victor V Fomin; Max J Hilz; Ana Jovanovic; Ilkka Kantola; Ales Linhart; Renzo Mignani; Mehdi Namdar; Albina Nowak; Oliveira, JP ; Maurizio Pieroni; Miguel Viana Baptista; Christoph Wanner; Marco Spada;
PUBLICAÇÃO: 2019, FONTE: MOLECULAR GENETICS AND METABOLISM REPORTS, VOLUME: 19
